by Mark Chiang

作者：马克·蒋

Share To

分享到

Slingshot AI has introduced a new therapy chatbot named Ash, which its founders claim is distinct from other mental health chatbots due to its training model. According to the company, Ash’s development relied on real therapeutic conversations rather than generalized or scripted data sets. The startup, backed by venture capital firm Andreessen Horowitz (a16z), aims to provide users with an innovative approach to mental health support through generative AI technology..

弹弓人工智能公司推出了一款名为Ash的新型治疗聊天机器人，其创始人声称，由于训练模型的不同，这款机器人与其他心理健康聊天机器人有所区别。据该公司介绍，Ash的开发依赖于真实的治疗对话，而非通用或脚本化的数据集。这家由风险投资公司安德森·霍洛维茨（a16z）支持的初创企业旨在通过生成式人工智能技术为用户提供一种创新的心理健康支持方式。

The chatbot’s creators state that Ash was designed using insights derived from authentic exchanges between therapists and patients. This approach reportedly allows the tool to simulate more nuanced and empathetic interactions compared to traditional AI models. Slingshot AI emphasizes that the chatbot is not intended to replace professional therapy but seeks to complement existing mental health resources by offering accessible support for individuals in need..

Ash 的创作者表示，Ash 是基于治疗师与患者之间的真实交流见解设计的。这种方法据称使该工具相比传统 AI 模型能够模拟出更加细致且富有同理心的互动。Slingshot AI 强调，这款聊天机器人并非旨在取代专业治疗，而是通过为有需要的个人提供可及的支持，来补充现有的心理健康资源。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: July 22, 2025

日期：2025年7月22日

Related posts:

相关内容：

Makary Addresses Agency, Remains Silent on Layoffs and Future Plans

马克里在机构发言，对裁员和未来计划保持沉默

Kennedy’s MAHA Commission, With One Meeting Held, Faces May 24 Deadline to Reduce Childhood Chronic Disease

肯尼迪的MAHA委员会已召开一次会议，面临5月24日减少儿童慢性病的最后期限

Eli Lilly Announces Pharmaceutical Sales Territory Manager Opening in South Bend Focused on GI Products

礼来公司宣布在南本德开设专注于胃肠道产品的制药销售区域经理职位

Researchers Develop Multi-Marker Method to Study Genetic Factors in Chronic Kidney Disease

研究人员开发出多标志物方法研究慢性肾病的遗传因素

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 保留所有权利。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

马克·江

Related Post

相关内容

News Flash

新闻快讯

FDA Sets March 6, 2026 Target Date to Review Sotyktu Application for Psoriatic Arthritis Treatment

FDA设定2026年3月6日为审查Sotyktu治疗银屑病关节炎申请的目标日期

2025-07-22

2025年7月22日